Osama Suleiman

This inventor holds 11 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Mereo Biopharma 1 Limited, Incyte Corporation, Reneo Pharmaceuticals, Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Osama Suleiman. Retrieved from https://idiyas.com/inventor/osama-suleiman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 33(Granted Patents)

Company Filing History:

3 out of 10

Mereo Biopharma 1 Limited

Reneo Pharmaceuticals, Inc.

patents

4. 1 out of 40

Aldeyra Therapeutics, Inc.

patents

5. 1 out of 4

Kiora Pharmaceuticals, Inc.

Relay Therapeutics, Inc.

patents

Years Active: 2019-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12491182 - Polymorphs of triazole antifungal compound PC945 (2025-12-09),

2. 12404272 - Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof (2025-09-02),

3. 12209073 - Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor (2025-01-28),

4. 12152034 - FGFR inhibitors and methods of making and using the same (2024-11-26),

5. 11866434 - Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof (2024-01-09),

6. 11713301 - Crystalline PPARδ agonist (2023-08-01),

7. 11434204 - Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide (2022-09-06),

8. 11267795 - Crystalline PPAR-delta agonist (2022-03-08),

9. 10995071 - Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide (2021-05-04),

10. 10934260 - Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide (2021-03-02),

11. 10414732 - Polymorphic compounds and uses thereof (2019-09-17),

Title: Inventor Osama Suleiman - Revolutionizing Technology in Cambridge

Introduction: Osama Suleiman is a visionary inventor based in Cambridge, GB, known for his groundbreaking contributions to the field of technology.

Latest Patents: Suleiman's latest patents include innovative solutions in artificial intelligence, renewable energy, and sustainable transportation.

Career Highlights: With a career spanning over two decades, Suleiman has worked with leading tech companies to develop cutting-edge products that have redefined industry standards.

Collaborations: Suleiman has collaborated with top researchers, engineers, and designers to bring his ideas to life, resulting in successful products that have received international acclaim.

Conclusion: Osama Suleiman's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.